Atacama was founded by a team of experienced life science professionals to test treatments for serious dermatology conditions with initial focus on a proof-of-concept trial for AT-5214 in Acne Vulgaris, a disease with a significant unmet medical need where few treatments have been approved by regulatory authorities.